Literature DB >> 11849122

Review article: natural history and epidemiology of Helicobacter pylori infection.

M F Go1.   

Abstract

Helicobacter pylori is a common bacterium infecting about half the world's population. It is causally linked with a diverse spectrum of gastrointestinal clinical disorders including peptic ulcer disease, gastric cancer, and gastric MALT lymphoma. The principal reservoir is the human stomach, and transmission probably occurs by person-to-person passage. Prevalence rates are generally much higher in developing countries compared to developed countries, although there are subgroups within many regions with higher H. pylori prevalence than in the general population. The prevalence of H. pylori varies by geographical location, ethnic background, socioeconomic conditions, and age. Recent studies suggest decreasing prevalence in developed countries or those with rapidly improving socioeconomic conditions. Comparative studies of the two fully sequenced H. pylori genomes are providing understanding of its large genetic diversity and bacterial virulence factors. The discovery of the type IV secretion system in H. pylori and its role in translocation of the CagA protein from the bacterial cell into the host epithelial cell provides insight into how host-bacterial interaction may lead to host disease. Cytokine promoter polymorphisms are determinants important in host gastric acid secretion status. Understanding the changing trends in H. pylori epidemiology, details of its transmission pathways, and the bacterial and host determinants leading to gastroduodenal disease remain the challenges in this area. Global epidemiological studies, advances in technology, and medical interventions have converged to help clarify the mechanisms of interaction between this ubiquitous micro-organism and its host that result in its diverse clinical manifestations.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11849122     DOI: 10.1046/j.1365-2036.2002.0160s1003.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  128 in total

Review 1.  Eradication of Helicobacter pylori: a clinical update.

Authors:  Marco Romano; Antonio Cuomo
Journal:  MedGenMed       Date:  2004-02-17

2.  Mucosal lymphocyte subsets and HLA-DR antigen expression in paediatric Helicobacter pylori-associated gastritis.

Authors:  A I Lopes; R M M Victorino; A M Palha; J Ruivo; A Fernandes
Journal:  Clin Exp Immunol       Date:  2006-07       Impact factor: 4.330

3.  Emerging role of IL-23/IL-17 axis in H pylori-associated pathology.

Authors:  Roberta Caruso; Francesco Pallone; Giovanni Monteleone
Journal:  World J Gastroenterol       Date:  2007-11-14       Impact factor: 5.742

Review 4.  Dealing with uncertainty in the treatment of Helicobacter pylori.

Authors:  Xavier Calvet
Journal:  Ther Adv Chronic Dis       Date:  2018-02-12       Impact factor: 5.091

5.  Meta-analysis of randomized controlled trials on the efficacy of probiotics in Helicobacter pylori eradication therapy in children.

Authors:  Shan Li; Xiu-li Huang; Jing-zhe Sui; Si-yuan Chen; Yan-tong Xie; Yan Deng; Jian Wang; Li Xie; Tai-jie Li; Yu He; Qi-liu Peng; Xue Qin; Zhi-yu Zeng
Journal:  Eur J Pediatr       Date:  2013-12-10       Impact factor: 3.183

6.  Neither gastric topological distribution nor principle virulence genes of Helicobacter pylori contributes to clinical outcomes.

Authors:  Yan-Wing Ho; Khek-Yu Ho; Felipe Ascencio; Bow Ho
Journal:  World J Gastroenterol       Date:  2004-11-15       Impact factor: 5.742

7.  RELATIONSHIP BETWEEN THE PRESENCE OF HELICOBACTER PYLORI WITH INFLAMMATORY ENDOSCOPIC CHANGES IN GASTRODUODENAL MUCOSA.

Authors:  Irma Cláudia Saboya Ribeiro; Luiz Fernandao Kubrusly; Paulo Afonso Nunes Nassif; Patrícia Fernanda Saboya Ribeiro; Rodrigo de Oliveira Veras; Aline Neppel
Journal:  Arq Bras Cir Dig       Date:  2016 Jul-Sep

8.  Helicobacter pylori flagellar hook-filament transition is controlled by a FliK functional homolog encoded by the gene HP0906.

Authors:  Kieran A Ryan; Najma Karim; Mulugeta Worku; Charles W Penn; Paul W O'Toole
Journal:  J Bacteriol       Date:  2005-08       Impact factor: 3.490

9.  Safety and efficacy of 1-week levofloxacin-based triple therapy in first-line treatment for Helicobacter pylori-related peptic ulcer disease in Kashmir, India.

Authors:  Altaf Shah; Gul Javid; Showkat Ali Zargar; Farooq Teli; Bashir Ahmad Khan; Ghulam Nabi Yattoo; Ghulam Mohammad Gulzar; Jaswinder Singh Sodhi; Mushtaq Ahmad Khan; Abid Shoukat; Reyaz Saif
Journal:  Indian J Gastroenterol       Date:  2012-12-08

10.  Potential protective effect of Helicobacter pylori on the development of gastrointestinal GvHD.

Authors:  A Velasco-Guardado; A Mora-Soler; L López-Corral; O López-Godino; L Vázquez-López; O Blanco-Muñez; E Pérez-López; A Rodríguez-Pérez; D Caballero-Barrigón
Journal:  Bone Marrow Transplant       Date:  2016-03-07       Impact factor: 5.483

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.